Study Highlights $1.5 Billion Savings in U.S. Drug Costs
ICER study shows aligning U.S. drug prices with health value benchmarks could save $1.5 billion and improve patient access. A
Read More
Factual Version of a Story
U.S. pharmaceutical innovation